Product
HMS5552
1 clinical trial
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
An Open-Label, Paralleled Study of the Pharmacokinetics of HMS5552 Following a Single Oral Dose in Mild and Moderate Hepatic Impaired Subjects and Matched Healthy VolunteersStatus: Completed, Estimated PCD: 2020-07-03